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Editorials
n the past decade, evidence-based clinical guidelines have
become a major feature of health care. Researchers and clini-
cians in many countries have established programs to summa-
rise the evidence for managing specific health problems and to
disseminate practice guidelines.
However, clinical use of guideline recommendations does not
necessarily follow. Numerous studies show that recommendations
are frequently not applied in practice and that many patients do
not profit from evidence-based in ights.1 Large variations in
performance between clinicians, practices and institutions are
commonly observed.
Two reports in this issue of the Journal on pages 305 and 310
illustrate this well.2,3 In the first, an audit in a hospital
outpatient clinic showed that large numbers of patients with
diabetes do not achieve recommended treatment targets for
control of glycaemia, blood pressure and lipid levels, despite
evidence that control of these risk factors produces better
outcomes.2 The second, a study of six Australian dialysis units,
showed that, despite high levels of awareness of iron guideline
recommendations in participating units, there is considerable
variation in achievement of targets and widely differing practices
in unit processes for iron management.3
Guidelines are expensive — the cost of producing a single
guideline may range from US$50 to US$500 000, not to mention
the substantial donated time from many contributors.4 Given the
lack of practical impact of many clinical guidelines, a critical
observer might well ask, “Why spend so much money and effort
on something that is so poorly adhered to in practice?” However,
the question should really be, “What can we do to increase the use
of best evidence guideline recommendations?”
Guideline developers, research funders, health care managers
and policymakers may need to consider a few key strategies:
• the need for greater focus on producing guidelines in formats
that promote their use;
• the requirement for planned (and funded) implementation
programs that take into account the complexity of change in health
care; and
• the need to improve our knowledge about cost-effective meth-
ods of achieving sustained practice changes.
Worldwide, many guideline developers give little considera-
tion to the use of their products in the real world. The reality is
that guidelines are too often “lost in translation”.5 Many current
programs for guideline development seem to be “science-driven”,
rather than scientifically based but “customer-driven”. Guideline
developers would do a far better job if they focused on the needs
of the end user and provided clear statements, decision aids,
patient education materials and practical tools to manage difficult
problems in practice. More guidelines need to identify specific
evidence-based indicators and criteria for clinical performance
(as the guidelines discussed in this issue of the Journal do). These
provide the capacity to monitor performance and give feedback
to clinicians. Public reporting of significant aspects of care
quality would help meet the urgent need in society for more
transparency about important aspects of health care provision,
and would provide a clear imperative to improve implementation
and ensure guideline recommendations are feasible and do not
become outdated.
There is also a need to seek a better balance between the
resources devoted to summarising evidence and developing
guidelines and those spent on finding the most effective ways to
improve patient care. Evidence-based guideline development
reflects just one specific approach to improving care — it
assumes that professionals are rational decisionmakers who will
act on convincing information about the pros and cons of
specific routines. Most of the time, effective change in health
care demands other models, ranging from those that emphasise
patient involvement in decision making to those that focus on
organisational development.6 Sadly, good evidence for the cost-
effectiveness of many of these strategies aiming to change
practice is lacking.6-8 Greater investment by research funders in
studies that would improve this knowledge base would help
direct implementation resources and effort to where they could
be of most use.
Policymakers who seek to change health care practices need
to understand that some current expectations about the impact
of clinical guidelines are unrealistic. A belief that developing
and disseminating systematic reviews and guidelines will
improve patient care ignores the complexity of change in health
care. Guidelines do not implement themselves — most need
well developed, well executed and sustained implementation
programs,7 and even such programs usually have only a
moderate effect on performance in terms of care improvement
(around 8%–10%).8 Many factors play crucial roles in blocking
or stimulating relevant changes in performance. These are not
only related to professional decision making, but also to patient
behaviour, interaction with colleagues, team functioning,
organisational conditions for change, resources, and economic
or legal conditions.7,9,10 This aspect was clearly demonstrated
in the renal impairment study.3 For most complex changes in
health care, we need to build bridges between the different
approaches to better care — guidelines, performance indicators
and feedback; patient empowerment; quality management;
organisational change; improving culture, teamwork and lead-
ership in the workplace; and creating the necessary financial
incentives.6
So, with a change of focus in current guideline development
and more realistic expectations of the role of guidelines in
improving patient care, with better knowledge about costs and
effects of change strategies, and with clinical guidelines embed-
ded in comprehensive programs for change, evidence-based
guidelines for clinical practice may become more relevant in the
future.
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